Yahoo Web Search

Lower COVID-19 Testing Revenues Hit LumiraDx Q2, Plans Cost Cutting Initiatives

LumiraDx Limited's (NASDAQ: LMDX) Q2 FY22 sales reached $44.7 million compared to Q1 2022 revenue of...